ARTMS
ARTMS Inc. (ARTMS) is pleased to announce that the acquisition by Telix Pharmaceuticals Limited (Telix) has been completed. This acquisition further enhances the vertical integration of Telix’s supply chain and manufacturing by providing a greater level of supply chain and regulatory control over the production of key isotopes.
ARTMS will support the high efficiency, large-scale and cost-effective production of commercially important medical isotopes for Telix’s portfolio of products, such as zirconium-89 (89Zr), gallium-68 (68Ga), technetium‐99m (99mTc) and copper-64 (64Cu), and will continue to partner with additional radiopharmaceutical companies to ensure that these critical isotopes are available on demand for patients. In addition, ARTMS’ portfolio of advanced cyclotron technologies has immediate application and differentiation for Telix in the production of future commercially important alpha-emitting, therapeutic isotopes, including actinium-225 (225Ac) and astatine-211 (211At).
The history of ARTMS is rooted in a Canadian government funded project focused on solid target production of 99mTc. After that project was successfully completed, the innovation continued and resulted in a full suite of PET products. In 2017, ARTMS Inc. was formed with support and seed funding from Quark Venture, through their Global Health Sciences Fund (GHS) and founding institutions TRIUMF, BC Cancer, Lawson Health Research Institute and the Center for Probe Development. In May of 2020, ARTMS completed a $20M USD Series A fundraising that included GHS and welcomed Deerfield Management to the ARTMS family. In the subsequent years ARTMS has played a critical role in alternative production of medical isotopes with a focus on accelerating the production capabilities of the world’s most commonly installed cyclotrons. The collaboration between ARTMS’ unparalleled team, its investors and founding members has resulted in a truly differentiated organization.
Solomon Partners Securities LLC acted as financial advisor and Norton Rose Fulbright Canada LLP acted as legal advisor to ARTMS during the negotiations and due diligence process related to the acquisition by Telix.
About ARTMS,
Based in Burnaby, British Columbia, Canada, ARTMS Inc. is the global leader in the development of novel technologies and products which enable the high-quality and high-yield production of the world’s most-used diagnostic imaging isotopes. ARTMS’ flagship product, the QUANTM Irradiation System (QISTM), enables decentralized, cost-effective, large-scale production of important medical isotopes such as gallium-68 (68Ga), zirconium-89 (89Zr), technetium‐99m (99mTc) and copper-64 (64Cu) using pharmaceutical distributor and hospital-based medical cyclotrons, empowering users to control their supply chain. ARTMS commercializes these award-winning and proprietary Canadian inventions on a global basis and has the prospect of revolutionizing the nuclear medicine industry.
For more information on the QUANTM Irradiation System™ and ARTMS, please follow us on Twitter/X @ARTMS_Inc/X and LinkedIn and visit http://www.artms.ca/
About Telix Pharmaceuticals Limited
Telix is a biopharmaceutical company focused on the development and commercialisation of diagnostic and therapeutic radiopharmaceuticals and associated medical devices. Telix is headquartered in Melbourne, Australia with international operations in the United States, Europe (Belgium and Switzerland), and Japan. Telix is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Telix is listed on the Australian Securities Exchange (ASX: TLX).
Visit www.telixpharma.com for further information about Telix, including details of the latest share price, announcements made to the ASX, investor and analyst presentations, news releases, event details and other publications that may be of interest. You can also follow Telix on X and LinkedIn.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240411054954/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Boomi Acquires Thru, Inc., Strengthening Secure Managed File Transfer (MFT) and Advancing Context-Aware Integration15.5.2025 15:00:00 CEST | Press release
Acquisition enhances Boomi’s MFT capabilities, unifying API, application, and file-based data movement within a single platform Boomi™, the leader in AI-driven automation, today announced a definitive agreement to acquire Thru, Inc., a provider of enterprise-grade Managed File Transfer solutions and trusted Boomi partner. The acquisition marks a strategic expansion of Boomi’s file-based integration capabilities, all within a single, cloud-native platform that seamlessly manages data movement across APIs, applications, and files. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250515314260/en/ Boomi Acquires Thru, Inc., Strengthening Secure Managed File Transfer (MFT) and Advancing Context-Aware Integration “As organizations increasingly manage a hybrid mix of API-based and file-based integrations, Thru, Inc.’s proven MFT technology ensures secure, scalable, and compliant file exchange across distributed business ecosystems,”
New York Mobile Becomes First U.S. MVNO to Launch on Telness Tech’s Seamless OS15.5.2025 15:00:00 CEST | Press release
New York Mobile is the first U.S. mobile virtual network operator (MVNO) to launch using Telness Tech’s newly launched Seamless OS platform. This deployment enables NY Mobile to deliver a next-generation wireless service, on T-Mobile’s largest and fastest 5G network. NY Mobile will be able to offer unprecedented features and flexibility for its customers including a vanity phone number marketplace and create-your-own-plan options. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250515669016/en/ from the left; Jonas Cedenwing (Founder & CTO Telness Tech) Giovanni Perone, Co-Founder & CEO at New York Mobile. Location; One World Trade Center (NY Mobile HQ). Photo taken by Sebastian Stecki. Customers can search and claim personalized phone numbers (including exclusive, previously exhausted area codes, creative number patterns, and words) through New York Mobile’s one-of-a-kind vanity number search engine and marketplace. This mak
Advanced Technologies Enable Reuse of 18.1 Billion Cubic Meters of Water15.5.2025 14:00:00 CEST | Press release
New report shows how utilities and businesses around the world are reusing water, preventing water loss, and creating more water-secure communities Utilities and businesses around the world have reused 18.1 billion cubic meters of water since 2019, enabled by solutions from global water technology leader Xylem (NYSE: XYL), the Company revealed in its most recent Sustainability Report. That volume is enough to meet the annual water needs of more than 350 million people, based on global use estimates.1 Reuse is just one part of a broader effort to increase global water security – alongside the implementation of advanced treatment and digital technologies. Water managers are using the innovations to protect water sources, remove contaminants, reduce emissions, and make water infrastructure more resilient. “Our customers are tackling the world’s toughest water challenges,” said Matthew Pine, Xylem President and Chief Executive Officer. “Their results show the impact of scaling proven techn
Rubicon Carbon Enters into Agreement with Microsoft for Nature-based Carbon Removal Credits15.5.2025 14:00:00 CEST | Press release
This initiative marks one of the largest-ever commitments by a single corporate buyer in the voluntary carbon market to date. Rubicon Carbon, a leading carbon credit management firm, today entered into a framework agreement with Microsoft to facilitate the purchase of 18 million tonnes of high-quality carbon removal credits – one of the largest single-buyer commitments of its kind in the world. Each carbon removal transaction under this deal will be structured as 15- to 20-year offtakes, supporting a pipeline of individual Afforestation, Reforestation, and Revegetation (ARR) projects worldwide. A defining feature of this framework agreement is the scale of Microsoft’s work in this space. By anchoring long-term offtake agreements, this deal demonstrates the growing role of corporate buyers in unlocking private investment for high-integrity carbon projects that might otherwise lack funding. “Addressing climate change requires more than good intentions—it requires capital deployment at sc
Horizon3.ai Gains FedRAMP High Authorization, Delivering on Its Commitment to Secure the Public Sector15.5.2025 14:00:00 CEST | Press release
Horizon3.ai, the global leader in offensive security, today announced it has gained Federal Risk and Authorization Management Program (FedRAMP®) High Authorization, unlocking the ability to support even the most security-sensitive federal missions. This milestone fulfills Horizon3.ai’s previously announced commitment to bring proof-based security to government agencies operating at the highest levels of compliance and risk exposure. Horizon3.ai’s newly authorized platform, NodeZero Federal™, is now available to federal agencies under the FedRAMP High baseline. Built upon the proven commercial version of the NodeZero® Offensive Security Platform, NodeZero Federal™ is designed specifically to meet the heightened security and compliance demands of government environments. With this authorization in place, Horizon3.ai becomes the first and only cybersecurity vendor authorized to deliver continuous, autonomous pentesting within this strict regulatory framework. “We built NodeZero to help de
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom